학술논문

Docetaxel Plus Ramucirumab With Primary Prophylactic Pegylated Granulocyte-Colony Stimulating Factor Support for Elderly Patients With Advanced NSCLC: A Multicenter Prospective Single Arm Phase 2 Trial: DRAGON Study (WJOG9416L)
Document Type
Article
Source
In JTO Clinical and Research Reports October 2023 4(10)
Subject
Language
ISSN
2666-3643